“This new indication is an important treatment advance for patients with this aggressive form of liver cancer, a community in need of new therapeutic options.”
– Michael M. Morrissey, Ph.D.,
President and Chief Executive Officer
Cancer is our Cause
We strive to develop effective, tolerable and durable
treatments so patients with cancer can thrive
Featured Patient Story
Breakthroughs come from collective experience, and ours is in the field of oncology. To date, three medicines discovered by Exelixis researchers are available to treat patients living with certain types of kidney cancer, thyroid cancer and advanced melanoma.
At Exelixis, everyone leads in our collective quest to drive for results so patients can have hope for remission.